| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.09.24 | Boeing Union Talks Collapse; No Future Negotiation Dates Set | 941 | AFX News | CHICAGO (dpa-AFX) - Boeing's (BA) union announced that talks with the Aerospace giant 'broke off' without reaching an agreement, and there are currently no further dates scheduled.In a post... ► Artikel lesen | |
| 28.09.24 | Volkswagen, Porsche Automobil Cut FY Outlook | 1.121 | AFX News | WOLFSBURG (dpa-AFX) - Volkswagen AG. (VKW.L, VLKAF.PK, VOW.BE) cut its forecast for the 2024 financial year in light of a challenging market environment. This decision comes after developments... ► Artikel lesen | |
| 28.09.24 | Medtronic's PulseSelect PFA System Shows 98% Pulmonary Vein Isolation In Atrial Fibrillation Study | 815 | AFX News | WASHINGTON (dpa-AFX) - Medtronic plc (MDT) announced that clinical study results demonstrated a high rate of durable lesion formation using the PulseSelect Pulsed Field Ablation (PFA) System... ► Artikel lesen | |
| 28.09.24 | J&J: DARZALEX FASPRO Quadruplet Regimen Improves MRD Negativity In Newly Diagnosed Multiple Myeloma | 889 | AFX News | NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced results from the Phase 3 CEPHEUS study demonstrating a significant clinical improvement with DARZALEX FASPRO (daratumumab and hyaluronidase-fihj)... ► Artikel lesen | |
| 28.09.24 | AbbVie Submits BLA To FDA For Telisotuzumab Vedotin In Previously Treated Non-Small Cell Lung Cancer | 903 | AFX News | WASHINGTON (dpa-AFX) - AbbVie (ABBV) announced submission of a Biologics License Application or BLA to the U.S. Food and Drug Administration for accelerated approval of telisotuzumab vedotin... ► Artikel lesen | |
| 28.09.24 | Unifor Files Notice Of Dispute Just Days Into Negotiations With Canadian National Railway | 852 | AFX News | OTTAWA (dpa-AFX) - Canadian National Railway Co. (CNI, CNR.TO) announced that labor union Unifor filed a Notice of Dispute three days after the beginning of negotiations. The Union represents... ► Artikel lesen | |
| 28.09.24 | J&J: Phase 3 Trial Results Show CARVYKTI Extends Overall Survival In Relapsed Multiple Myeloma | 770 | AFX News | NEW BRUNSWICK (dpa-AFX) - Janssen-Cilag International NV, a Johnson & Johnson company, announced three-year follow-up data from the Phase 3 CARTITUDE-4 study that showed a single infusion of... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 347 |
| NOVO NORDISK | 235 |
| BAYER | 201 |
| EVOTEC | 185 |
| PUMA | 184 |
| BASF | 183 |
| TUI | 178 |
| TESLA | 173 |
| DEUTSCHE BANK | 134 |
| NEL | 133 |
| D-WAVE QUANTUM | 129 |
| MICROSTRATEGY | 120 |
| DEUTSCHE TELEKOM | 111 |
| RHEINMETALL | 111 |
| COMMERZBANK | 108 |
| PLUG POWER | 107 |
| DEUTSCHE LUFTHANSA | 96 |
| BYD | 94 |
| BIONTECH | 90 |
| HEIDELBERGER DRUCK | 89 |
| PROSIEBENSAT.1 | 88 |
| THYSSENKRUPP | 84 |
| RWE | 82 |
| SIEMENS ENERGY | 78 |
| E.ON | 75 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
